A composition comprising at least one dispersed fatty phase, and at least one continuous aqueous phase, and comprising: a) at least one hydrophobic gelling agent selected from ester of dextrin and fatty acid; b) at least one amphiphilic crosslinked copolymer; c) at least one anionic terpolymer, linear or branched, of at least one monomer (1) carrying an acid function in free form, partially or totally salified by a nonionic monomer (2) selected from N,N-dimethylacrylamide and 2-hydroxyethyl acrylate, and at least one monomer (3) polyoxethylenated alkyl acrylate of formula (III) wherein in formula (III): R1 represents a hydrogen atom, R represents a linear or branched C.sub.8-C.sub.16 alkyl radical, n is an integer ranging from 1 to 10; and d) at least one hydrophobic particles chosen from hydrophobic silicas, hydrophobic cellulose, starch, talc, silicone resin powders, hollow hemispherical silicone particles, polyamide powders, hydrophobic pigments, or a mixture thereof. ##STR00001##

A composition comprising at least one dispersed fatty phase, and at least one continuous aqueous phase, and comprising: a) at least one hydrophobic gelling agent selected from ester of dextrin and fatty acid; b) at least one amphiphilic crosslinked copolymer; c) at least one anionic terpolymer, linear or branched, of at least one monomer (1) carrying an acid function in free form, partially or totally salified by a nonionic monomer (2) selected from N,N-dimethylacrylamide and 2-hydroxyethyl acrylate, and at least one monomer (3) polyoxethylenated alkyl acrylate of formula (III) wherein in formula (III): R1 represents a hydrogen atom, R represents a linear or branched C.sub.8-C.sub.16 alkyl radical, n is an integer ranging from 1 to 10; and d) at least one hydrophobic particles chosen from hydrophobic silicas, hydrophobic cellulose, starch, talc, silicone resin powders, hollow hemispherical silicone particles, polyamide powders, hydrophobic pigments, or a mixture thereof. ##STR00001##

A deodorizing composition includes cucurbituril and one or more first metal salts, the first metal salt including at least one metal cation with a valency of at least two and at least one anion, wherein the metal cation is selected from the group made of aluminium, zirconium, silver, titanium, iron, copper, zinc, and magnesium cations.

The present disclosure relates to antiperspirant cosmetic agents, in the case of which the total amount of antiperspirant compounds can be clearly reduced without the antiperspirant effect of said agents or the storage stability of said agents being impaired, comprising—in each case with respect to the total weight of the antiperspirant cosmetic agent—a) 1 to 30 wt % of at least one antiperspirant compound, b) 0.1 to 10 wt % of salicylic acid, c) at least one compound of formula (I), in which n represents 0 or 1, X represents —H, Na+, K+, or NH4+, R1 is selected from —H, —COOX, or —(CH2)—COOX, R2 is selected from —H, C1-10 alkyl, or COOX, R3 is selected from —(CH2)—COOX, —(CH2)2-N[(CH2)—COOX]2, —CH(R1)—COOX, —(CH2)2-NH[CH(COOX)(CH2COOX)], —CH(R4)—C(R5)(R6)—COOX, R4 is selected from —H, C1-10 alkyl, or COOX, and R5 and R6 are, independently of each other, —H, —OH, or C1-10 alkyl.

The present disclosure relates to antiperspirant cosmetic agents, in the case of which the total amount of antiperspirant compounds can be clearly reduced without the antiperspirant effect of said agents or the storage stability of said agents being impaired, comprising—in each case with respect to the total weight of the antiperspirant cosmetic agent—a) 1 to 30 wt % of at least one antiperspirant compound, b) 0.1 to 10 wt % of salicylic acid, c) at least one compound of formula (I), in which n represents 0 or 1, X represents —H, Na+, K+, or NH4+, R1 is selected from —H, —COOX, or —(CH2)—COOX, R2 is selected from —H, C1-10 alkyl, or COOX, R3 is selected from —(CH2)—COOX, —(CH2)2-N[(CH2)—COOX]2, —CH(R1)—COOX, —(CH2)2-NH[CH(COOX)(CH2COOX)], —CH(R4)—C(R5)(R6)—COOX, R4 is selected from —H, C1-10 alkyl, or COOX, and R5 and R6 are, independently of each other, —H, —OH, or C1-10 alkyl.

The present invention provides a nitric-oxide containing composite in the form of microparticles, wherein said microparticles comprise: (i) a core which comprises silica; (ii) a layer on said core which comprises a metal-organic framework; and (iii) nitric oxide;
wherein said metal-organic framework comprises organic ligands comprising at least one amine group, said metal-organic framework is uniformly distributed on the surface of said silica core and said nitric oxide is chemisorbed within said metal-organic framework.

The present invention provides a nitric-oxide containing composite in the form of microparticles, wherein said microparticles comprise: (i) a core which comprises silica; (ii) a layer on said core which comprises a metal-organic framework; and (iii) nitric oxide;
wherein said metal-organic framework comprises organic ligands comprising at least one amine group, said metal-organic framework is uniformly distributed on the surface of said silica core and said nitric oxide is chemisorbed within said metal-organic framework.

The present invention relates to methods and compositions for the treatment of dermatophytic conditions such as tinea pedis. Such conditions can progress through multiple stages, such as fungal and bacterial stages, making effective treatment results difficult to achieve. The invention relates to a combined therapy effective for treatment of the condition that utilizes daily administration of a balanced combination of antifungals, antiperspirants and drying agents to achieve a beneficial therapeutic effect, irrespective of the stage of the disease upon commencement of the treatment.

The present invention relates to methods and compositions for the treatment of dermatophytic conditions such as tinea pedis. Such conditions can progress through multiple stages, such as fungal and bacterial stages, making effective treatment results difficult to achieve. The invention relates to a combined therapy effective for treatment of the condition that utilizes daily administration of a balanced combination of antifungals, antiperspirants and drying agents to achieve a beneficial therapeutic effect, irrespective of the stage of the disease upon commencement of the treatment.

A skin tightening composition including about 2 to about 35 wt. % of at least one thickener selected from polyamide-8, styrene ethylene/propylene copolymer, nylon-611/dimethicone crosspolymer, VP/EICOSENE copolymer, fumed silicas, hydrophobically modified silica, silica silylate, clays and a combination thereof; about 1.5 to about 13 wt. % of at least one filler; about 5 to about 45 wt. % of at least one hydrophobic film former; and about 20 to about 85 wt. % of at least one volatile hydrocarbon, wherein a weight ratio of the at least one hydrophobic film former c) to the at least one thickener a) is 1:2 to 8:1 (hydrophobic film former c):thickener a)), and all weight percentages are based on the total weight of the skin tightening composition.